Drug

Deserpidine

As of the edition of 20 October 2026, Deserpidine is a small molecule: marketed, first approved in 1982 (US); acts on SLC18A2; no US protection is listed.

Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.

The drug

Status
Marketed; latest approval 1982
Kind
Small molecule
Brand name
Harmonyl
First approved
1 January 1982 (US)
Approvals on record
7 in 1 region
Holder of the most recent approval
AbbVie; 2 holders in all

US protection

No US protection is listed.

The FDA registers list no drug-substance patent or exclusivity that counts for this drug.

This is the US only.

Target

GeneProteinUniProt
SLC18A2Synaptic vesicular amine transporterQ05940

Who has held its approvals

CompanyRoleYears
AbbVieAcquired holder2012 to now
AbbottEarlier holder